# bioAffinity Technologies, Inc.: filings

BIAF · Nasdaq · CIK 1712762 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/biaf.md) · [Financials](/companies/biaf/financials.md) · [Filings](/companies/biaf/filings.md) · [Insiders](/companies/biaf/insiders.md)

## Reports and events: 174 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (8-K 126, 4 62, CORRESP 36, 3 18, EFFECT 15, 424B3 14, UPLOAD 14, 10-Q 12, 424B5 12, S-1 11, S-1/A 10, DEF 14A 8, PRE 14A 8, D 5, DRS 5, 10-K 4, 424B4 4, POS AM 4, S-8 4, ARS 3, DEFA14A 3, PRER14A 3, 8-K/A 2, S-3 2, SCHEDULE 13G 2, 10-K/A 1, 8-A12B 1, 8-A12B/A 1, CERT 1, DRSLTR 1, FWP 1, RW 1, S-3/A 1, S-8 POS 1, SC 13G 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-29 | 08:30 ET | [8-K](/filings/0001493152-26-049188.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-049188 |
| 2026-10-23 | 16:30 ET | [DEF 14A](/filings/0001493152-26-048245.md) | Proxy statement, period 2026-10-23 | 0001493152-26-048245 |
| 2026-10-15 | 09:30 ET | [8-K](/filings/0001493152-26-047168.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-047168 |
| 2026-10-13 | 09:23 ET | [8-K](/filings/0001493152-26-046755.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-046755 |
| 2026-10-09 | 16:30 ET | [8-K](/filings/0001493152-26-046548.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-046548 |
| 2026-10-08 | 08:30 ET | [8-K](/filings/0001493152-26-046266.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-046266 |
| 2026-10-06 | 08:30 ET | [8-K](/filings/0001493152-26-045867.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-045867 |
| 2026-09-30 | 08:30 ET | [8-K](/filings/0001493152-26-045034.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-045034 |
| 2026-09-22 | 08:30 ET | [8-K](/filings/0001493152-26-043654.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-043654 |
| 2026-09-17 | 08:30 ET | [8-K](/filings/0001493152-26-043052.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-043052 |
| 2026-09-11 | 08:30 ET | [8-K](/filings/0001493152-26-042304.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-042304 |
| 2026-09-09 | 08:30 ET | [8-K](/filings/0001493152-26-041894.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-041894 |
| 2026-09-03 | 16:55 ET | [8-K](/filings/0001493152-26-041387.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-041387 |
| 2026-09-01 | 16:30 ET | [8-K](/filings/0001493152-26-041020.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-041020 |
| 2026-08-20 | 08:30 ET | [8-K](/filings/0001493152-26-039375.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-039375 |
| 2026-08-18 | 08:30 ET | [8-K](/filings/0001493152-26-038897.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-038897 |
| 2026-08-14 | 16:30 ET | [8-K](/filings/0001493152-26-038437.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-038437 |
| 2026-08-07 | 16:45 ET | [10-Q](/filings/0001493152-26-036619.md) | Quarterly report, period 2026-06-30 | 0001493152-26-036619 |
| 2026-08-07 | 08:30 ET | [8-K](/filings/0001493152-26-036486.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-26-036486 |
| 2026-07-31 | 17:15 ET | [8-K](/filings/0001493152-26-035672.md) | 3.01 Delisting notice | 0001493152-26-035672 |
| 2026-07-27 | 08:30 ET | [8-K](/filings/0001493152-26-034711.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-034711 |
| 2026-07-22 | 08:30 ET | [8-K](/filings/0001493152-26-034183.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-034183 |
| 2026-07-07 | 08:54 ET | [8-K](/filings/0001493152-26-032263.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-032263 |
| 2026-06-30 | 17:19 ET | [8-K](/filings/0001493152-26-031327.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-031327 |
| 2026-06-18 | 17:07 ET | [8-K](/filings/0001493152-26-029384.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-029384 |
| 2026-06-16 | 16:00 ET | [S-1/A](/filings/0001493152-26-028877.md) | Registration statement, amended | 0001493152-26-028877 |
| 2026-06-16 | 08:30 ET | [8-K](/filings/0001493152-26-028823.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-028823 |
| 2026-06-12 | 17:09 ET | [S-1](/filings/0001493152-26-028507.md) | Registration statement | 0001493152-26-028507 |
| 2026-06-02 | 08:30 ET | [8-K](/filings/0001493152-26-026773.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-026773 |
| 2026-05-27 | 08:30 ET | [8-K](/filings/0001493152-26-025338.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-025338 |
| 2026-05-12 | 09:20 ET | [8-K](/filings/0001493152-26-022428.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-022428 |
| 2026-05-11 | 18:27 ET | [10-Q](/filings/0001493152-26-022044.md) | Quarterly report, period 2026-03-31 | 0001493152-26-022044 |
| 2026-05-08 | 08:30 ET | [8-K](/filings/0001493152-26-021861.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-26-021861 |
| 2026-04-30 | 17:07 ET | [S-1](/filings/0001493152-26-020725.md) | Registration statement | 0001493152-26-020725 |
| 2026-04-30 | 16:30 ET | [8-K](/filings/0001493152-26-020591.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-26-020591 |
| 2026-04-14 | 08:30 ET | [8-K](/filings/0001493152-26-016486.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-016486 |
| 2026-04-07 | 08:30 ET | [8-K](/filings/0001493152-26-015445.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-015445 |
| 2026-04-01 | 16:15 ET | [8-K](/filings/0001493152-26-014653.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-014653 |
| 2026-03-26 | 08:00 ET | [8-K](/filings/0001493152-26-012808.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-012808 |
| 2026-03-25 | 16:30 ET | [8-K](/filings/0001493152-26-012683.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-012683 |
| 2026-03-17 | 16:30 ET | [8-K](/filings/0001493152-26-010584.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-010584 |
| 2026-03-16 | 17:15 ET | [DEF 14A](/filings/0001493152-26-010314.md) | Proxy statement, period 2026-03-16 | 0001493152-26-010314 |
| 2026-03-16 | 21:50 ET | [10-K](/filings/0001493152-26-010143.md) | Annual report, period 2025-12-31 | 0001493152-26-010143 |
| 2026-03-13 | 08:30 ET | [8-K](/filings/0001493152-26-009986.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-26-009986 |
| 2026-03-10 | 08:45 ET | [8-K](/filings/0001493152-26-009463.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-009463 |
| 2026-03-06 | 16:30 ET | [8-K](/filings/0001493152-26-009154.md) | 5.02 Departure or appointment of officers or directors | 0001493152-26-009154 |
| 2026-03-03 | 16:27 ET | [8-K](/filings/0001493152-26-008723.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-008723 |
| 2026-02-25 | 09:00 ET | [8-K](/filings/0001493152-26-007965.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-007965 |
| 2026-02-19 | 16:01 ET | [8-K](/filings/0001493152-26-007464.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-007464 |
| 2026-02-17 | 16:30 ET | [8-K](/filings/0001493152-26-007139.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-007139 |

Page 1 of 4. [Older](/companies/biaf/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 08:32 ET. No prices; not investment advice.